| dc.creator | Fountas K.N. | en |
| dc.date.accessioned | 2023-01-31T07:38:34Z | |
| dc.date.available | 2023-01-31T07:38:34Z | |
| dc.date.issued | 2020 | |
| dc.identifier | 10.3390/brainsci10040237 | |
| dc.identifier.issn | 20763425 | |
| dc.identifier.uri | http://hdl.handle.net/11615/71716 | |
| dc.description.abstract | [No abstract available] | en |
| dc.language.iso | en | en |
| dc.source | Brain Sciences | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083766122&doi=10.3390%2fbrainsci10040237&partnerID=40&md5=7a5474d2ab34042528668812251a53dc | |
| dc.subject | fluorescein sodium | en |
| dc.subject | accuracy | en |
| dc.subject | cancer cell | en |
| dc.subject | craniotomy | en |
| dc.subject | Editorial | en |
| dc.subject | efficacy parameters | en |
| dc.subject | electrostimulation | en |
| dc.subject | evidence based medicine | en |
| dc.subject | fluorescent guided surgery | en |
| dc.subject | functional magnetic resonance imaging | en |
| dc.subject | glioblastoma | en |
| dc.subject | glioma | en |
| dc.subject | health care | en |
| dc.subject | health service | en |
| dc.subject | human | en |
| dc.subject | incidence | en |
| dc.subject | neurological deficit score | en |
| dc.subject | neurosurgery | en |
| dc.subject | overall survival | en |
| dc.subject | peroperative care | en |
| dc.subject | predictive value | en |
| dc.subject | progression free survival | en |
| dc.subject | quality of life assessment | en |
| dc.subject | Raman spectrometry | en |
| dc.subject | randomized controlled trial (topic) | en |
| dc.subject | supramarginal gyrus | en |
| dc.subject | surgical technique | en |
| dc.subject | ultrasound | en |
| dc.subject | MDPI AG | en |
| dc.title | Fluorescent guided surgery in the surgical management of glioma: The dawn of a new era | en |
| dc.type | other | en |